Company: NDRA
Filing Date: 2025-05-09
Form Type: DRS
Source: 0001654954-25-005304
Chunk: 22

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-05-09
Form: DRS
Chunk 22
---
 the meeting, or by request of the holders of record of at least 20% of the outstanding shares of common stock. This provision could prevent stockholders from calling a special meeting because, unless certain significant stockholders were to join with them, they might not obtain the percentage necessary to request the meeting. Therefore, stockholders holding less than 20% of the issued and outstanding common stock, without the assistance of management, may be unable to propose a vote on any transaction that would delay, defer or prevent a change of control, even if the transaction were in the best interests of our stockholders.

Transfer Agent

The transfer agent for our common stock is VStock Transfer, LLC.

Listing of Securities

Our common stock is listed on the Nasdaq Capital Market under the symbol “NDRA.”

| 20 |

<div align='center'>CONFIDENTIAL TREATMENT REQUESTED PURSUANT TO 17 C.F.R. § 200.83

UNDERWRITING</div>

is acting as the sole underwriter of this offer ( , or the “Underwriter”). We entered into an underwriting agreement with with respect to the securities subject to this offering. Subject to the terms and conditions stated in the underwriting agreement dated the date of this prospectus, the Underwriter has agreed to purchase, and we have agreed to sell to the Underwriter, the number of shares of common stock shown in the table below:

| Underwriter |     | Number of shares |
| Total       |     |                  |

The Underwriting Agreement provides that the obligations of the Underwriter to purchase the shares included in this offering are subject to approval of legal matters by counsel and to other conditions. The Underwriting Agreement provides that the Underwriter will purchase all of the shares of common stock if any of them are purchased.

Shares of our common stock sold by the Underwriter to the public will initially be offered at the public offering price set forth on the cover of this prospectus. In addition, the Underwriter may offer some of the securities to other securities dealers at such price less a concession of $ per share. After the initial offering of the shares of common stock, the public offering price or any other term of the offering may be changed by the Underwriter.

Underwriting discounts and commissions

We are offering shares of our common pursuant to this prospectus. The following table shows the effective public offering price per share of common stock public offering price, underwriting discounts and commissions, and proceeds before expenses to us.

|                                                                                 |     | Effective Price Per